Drug Shortage Report for MYLAN-RISPERIDONE ODT

Last updated on 2021-11-23 History
Report ID 3360
Drug Identification Number 02413485
Brand name MYLAN-RISPERIDONE ODT
Common or Proper name RISPERIDONE ODT
Company Name MYLAN PHARMACEUTICALS ULC
Market Status DORMANT
Active Ingredient(s) RISPERIDONE
Strength(s) 0.5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 100BT
ATC code N05AX
ATC description ANTIPSYCHOTICS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-04-24
Estimated end date Unknown
Actual end date 2021-11-15
Shortage status Resolved
Updated date 2021-11-23
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v51 2021-11-23 French Compare
v50 2021-11-23 English Compare
v49 2020-01-09 French Compare
v48 2020-01-09 English Compare
v47 2019-02-21 French Compare
v46 2019-02-21 English Compare
v45 2018-11-06 French Compare
v44 2018-11-06 English Compare
v43 2018-10-03 French Compare
v42 2018-10-03 English Compare
v41 2018-08-28 French Compare
v40 2018-08-28 English Compare
v39 2018-07-25 French Compare
v38 2018-07-25 English Compare
v37 2018-07-16 French Compare
v36 2018-07-16 English Compare
v35 2018-05-23 French Compare
v34 2018-05-23 English Compare
v33 2018-05-18 French Compare
v32 2018-05-18 English Compare

Showing 1 to 20 of 51